13 employees
Biotx.ai delivers next-generation biomarkers as a basis for decision support in precision medicine.
2017
biotx.ai raised undisclosed on April 5, 2023
Investors: Oxford Angel Fund
biotx.ai raised undisclosed on November 8, 2021
Investors: protocol — by gettylab
biotx.ai raised undisclosed on June 17, 2019
Investors: Creative Destruction Lab